The Impact of Ampreloxetine on Supine Hypertension: An Ambulatory Blood Pressure Monitoring Study. (S9.002)
To determine the impact of ampreloxetine (oral, 10 mg/day) on supine hypertension as assessed by ambulatory blood pressure (BP) monitoring.
Authors
- Roy Freeman (ORCID: https://orcid.org/0000-0003-3976-6022)
- Italo Biaggioni (ORCID: https://orcid.org/0000-0001-7667-7083)
- Lucy Norcliffe‐Kaufmann (ORCID: https://orcid.org/0000-0003-0702-1333)
- Horacio Kaufmann (ORCID: https://orcid.org/0000-0002-1851-9981)
- Alessandra Fanciulli (ORCID: https://orcid.org/0000-0002-2854-4179)
- Ross G. Vickery
- Tadhg Geurin
Institutions
- Innsbruck Medical University (AT)
- Universität Innsbruck (AT)
- NYU Langone Health (US)
- Theravance Biopharma (United States) (US)
Publication Details
- Journal
- Neurology
- Published
- 2025-04-07
- DOI
- https://doi.org/10.1212/wnl.0000000000212055
- Primary Topic
- Treatment of Major Depression
- Type
- article
- Field-Weighted Citation Impact
- 0.00